CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $44.41 ($444,100)
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · New debt or obligation
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $44.36 ($443,600)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $55.86 ($558,600)
- 8-K Event Agreement ended · Executive or director change
- 4 Open-market sale Director sold 800,000 shares at an average $54.54 ($43,631,250)
- SC 13D/A Stake Beneficial Ownership Report
- NT 10-Q Other NT 10-Q
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $40.07 ($400,700)
- 8-K Event Material agreement
Page 13 of 21 · 416 filings